These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 18799050)
1. Giant cell arteritis: intensity of the initial systemic inflammatory response and the course of the disease. Nesher G; Nesher R; Mates M; Sonnenblick M; Breuer GS Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S30-4. PubMed ID: 18799050 [TBL] [Abstract][Full Text] [Related]
2. A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Hernández-Rodríguez J; García-Martínez A; Casademont J; Filella X; Esteban MJ; López-Soto A; Fernández-Solà J; Urbano-Márquez A; Grau JM; Cid MC Arthritis Rheum; 2002 Feb; 47(1):29-35. PubMed ID: 11932875 [TBL] [Abstract][Full Text] [Related]
3. Association between histological features in temporal artery biopsies and clinical features of patients with giant cell arteritis. Breuer GS; Nesher R; Reinus K; Nesher G Isr Med Assoc J; 2013 Jun; 15(6):271-4. PubMed ID: 23882888 [TBL] [Abstract][Full Text] [Related]
4. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883 [TBL] [Abstract][Full Text] [Related]
5. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives. Ferraccioli GF; Di Poi E; Damato R Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S58-60. PubMed ID: 10948766 [TBL] [Abstract][Full Text] [Related]
6. Polymyalgia rheumatic (PMR): giant cell arteritis (GCA). Kelly MC Ir Med J; 2008; 101(7):222-4. PubMed ID: 18807817 [No Abstract] [Full Text] [Related]
7. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. Bahlas S; Ramos-Remus C; Davis P J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211 [TBL] [Abstract][Full Text] [Related]
8. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis. Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588 [TBL] [Abstract][Full Text] [Related]
9. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review. Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026 [TBL] [Abstract][Full Text] [Related]
10. Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study. Restuccia G; Boiardi L; Cavazza A; Catanoso M; Macchioni P; Muratore F; Cimino L; Aldigeri R; Crescentini F; Pipitone N; Salvarani C Medicine (Baltimore); 2016 May; 95(19):e3524. PubMed ID: 27175649 [TBL] [Abstract][Full Text] [Related]
11. [Polymyalgia rheumatica and giant-cell temporal arteritis]. Tereshchenko IV Klin Med (Mosk); 2006; 84(8):25-30. PubMed ID: 17087187 [TBL] [Abstract][Full Text] [Related]